Home › Calculator › NEO Dividend Calculator 2026
NEO Dividend DRIP Calculator 2026
11.51% YieldHealthcareNeoGenomics, Inc. · NASDAQ
Price: $17.38 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When NEO pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your NEO snowball 📈
$10,000 in NEO → $280.9K in 10 years · $0.10/month
About NeoGenomics, Inc. (NEO) — Dividend Analysis 2026
NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical Services and Pharma Services. Its comprehensive offerings cater to a diverse clientele, including hospitals, reference laboratories, pathologists, oncologists, clinicians, pharmaceutical companies, and researchers. NeoGenomics' advanced testing capabilities encompass cytogenetics, which examines normal and abnormal chromosomes in relation to disease; fluorescence in-situ hybridization (FISH) for detecting and pinpointing specific DNA sequences and genes on chromosomes; and flow cytometry, used to measure cell population characteristics. Additionally, the company provides immunohistochemistry and digital imaging services, enabling the localization of cellular proteins in tissue sections, visualization of scanned slides, and quantitative analysis. Molecular testing, focusing on DNA/RNA analysis and gene structure/function, is also a key offering, alongside morphologic analysis where pathologists microscopically diagnose cells. Beyond clinical diagnostics, NeoGenomics supports pharmaceutical clients' oncology programs from discovery to commercialization and acts as a reference laboratory for anatomic pathology testing. The company, founded in 2001 and headquartered in Fort Myers, Florida, also maintains a strategic alliance and laboratory services agreement with Inivata Limited.
Compare NEO with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full NEO DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open NEO position with:
🌍 NEO Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold NEO.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 11.51% | 8.71% | $1,151 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 9.78% | 6.98% | $978 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 9.21% | 6.41% | $921 / yr |
| 🇬🇧 UK ISA | 0% | 11.51% | 8.71% | $1,151 / yr |
| 🇬🇧 UK Taxable | 8.75% | 10.50% | 7.70% | $1,050 / yr |
| 🇨🇦 TFSA | 0% | 11.51% | 8.71% | $1,151 / yr |
| 🇨🇦 CA Taxable | 25% | 8.63% | 5.83% | $863 / yr |
| 🇦🇺 Super (pension) | 15% | 9.78% | 6.98% | $978 / yr |
| 🇦🇺 AU Taxable | 30% | 8.06% | 5.26% | $806 / yr |
| 🇩🇪 DE Taxable | 26.375% | 8.47% | 5.67% | $847 / yr |
| 🇫🇷 FR Taxable | 30% | 8.06% | 5.26% | $806 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 NEO Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 NEO Dividend Payment Schedule
NEO pays quarterly — 4 times per year. Next ex-div: TBD.
📊 NEO vs Healthcare Benchmarks
How NEO compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NEO sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ NEO Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NEO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
NeoGenomics, Inc. (NEO) is currently trading at $17.38, 68% below its 52-week high. The current dividend yield is 11.51% based on an annual payout of $2.00 per share.
NEO (NeoGenomics, Inc.) — 11.51% Dividend Yield Analysis
NeoGenomics, Inc. (NEO) is a healthcare stock currently trading at $17.38 with a dividend yield of 11.51%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, NEO has grown its dividend at a compound annual rate of 50.0%.
- Above-average yield (11.51%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.